Gepotidacin could be new treatment option for gonorrhea, suggests Phase 3 trial Jacinthlyn Sylvia21 April 2025 8:30 AM ISTA new study published in the journal of The Lancet showed that, with no new safety issues, gepotidacin showed no inferiority to ceftriaxone with...
FDA Approves Gepotidacin for Uncomplicated UTIs Dr. Kamal Kant Kohli26 March 2025 8:45 PM ISTThe FDA has approved GSK's gepotidacin (Blujepa) for treating uncomplicated urinary tract infections (uUTIs) in females aged 12 and older. The...
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and older Ruchika Sharma26 March 2025 11:15 AM ISTLondon: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa (gepotidacin) for the...
Gepotidacin potential novel oral treatment option for uncomplicated gonorrhoea: EAGLE-1 phase III trial shows Medha Baranwal2 March 2024 2:15 AM ISTUK: Gepotidacin, a first-in-class triazaacenaphthylene antibiotic, demonstrated non-inferiority to the current standard-of-care gonorrhoea treatment...
GSK posts positive headline results from phase III trial for Gepotidacin in uncomplicated urogenital gonorrhoea Ruchika Sharma27 Feb 2024 2:30 PM ISTGSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, a potential first-in-class oral antibiotic...
Novel antibiotic Gepotidacin safe, tolerable and effective option against UTI: Lancet Jacinthlyn Sylvia14 Feb 2024 7:30 PM ISTIn a recent study, a novel antibiotic, the Gepotidacin has demonstrated promising efficacy and safety in clinical trials against urinary tract...
GSK oral antibiotic drug to treat uncomplicated urinary tract infections meets main goals in late stage trials Ruchika Sharma17 April 2023 2:39 PM ISTThe drug, if approved, could become the first new type of antibiotic, which is critically important for countering drug-resistant infections, to treat...
Novel drug gepotidacin for uncomplicated UTI meets trial goals Dr. Kamal Kant Kohli4 Nov 2022 10:00 PM ISTPharmaceutical giant Glaxo Smith Kline has announced today that two clinical trials for an investigational antibiotic gepotidacin for use in...
